Core Genome Multilocus Sequence Typing for Food Animal Source Attribution of Human Campylobacter jejuni Infections by Hsu, Chih-Hao et al.
Veterinary Microbiology and Preventive 
Medicine Publications 
Veterinary Microbiology and Preventive 
Medicine 
7-2-2020 
Core Genome Multilocus Sequence Typing for Food Animal 
Source Attribution of Human Campylobacter jejuni Infections 
Chih-Hao Hsu 
United States Food and Drug Administration 
Lucas Harrison 
United States Food and Drug Administration 
Sampa Mukherjee 
United States Food and Drug Administration 
Errol Strain 
United States Food and Drug Administration 
Patrick McDermott 
United States Food and Drug Administration 
See next page for additional authors 
Follow this and additional works at: https://lib.dr.iastate.edu/vmpm_pubs 
 Part of the Veterinary Pathology and Pathobiology Commons 
The complete bibliographic information for this item can be found at https://lib.dr.iastate.edu/
vmpm_pubs/213. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html. 
This Article is brought to you for free and open access by the Veterinary Microbiology and Preventive Medicine at 
Iowa State University Digital Repository. It has been accepted for inclusion in Veterinary Microbiology and 
Preventive Medicine Publications by an authorized administrator of Iowa State University Digital Repository. For 
more information, please contact digirep@iastate.edu. 
Core Genome Multilocus Sequence Typing for Food Animal Source Attribution of 
Human Campylobacter jejuni Infections 
Abstract 
Campylobacter jejuni is a major foodborne pathogen and common cause of bacterial enteritis worldwide. 
A total of 622 C. jejuni isolates recovered from food animals and retail meats in the United States through 
the National Antimicrobial Resistance Monitoring System between 2013 and 2017 were sequenced using 
an Illumina MiSeq. Sequences were combined with WGS data of 222 human isolates downloaded from 
NCBI and analyzed by core genome multilocus sequence typing (cgMLST) and traditional MLST. cgMLST 
allelic difference (AD) thresholds of 0, 5, 10, 25, 50, 100 and 200 identified 828, 734, 652, 543, 422, 298 
and 197 cgMLST types among the 844 isolates, respectively, and traditional MLST identified 174 ST. The 
cgMLST scheme allowing an AD of 200 (cgMLST200) revealed strong correlation with MLST. cgMLST200 
showed 40.5% retail chicken isolates, 56.5% swine, 77.4% dairy cattle and 78.9% beef cattle isolates 
shared cgMLST sequence type with human isolates. All ST-8 had the same cgMLST200 type 
(cgMLST200-12) and 74.3% of ST-8 and 75% cgMLST200-12 were confirmed as sheep abortion virulence 
clones by PorA analysis. Twenty-nine acquired resistance genes, including 21 alleles of blaOXA, tetO, 
aph(3′)-IIIa, ant(6)-Ia, aadE, aad9, aph(2′)-Ig, aph(2′)-Ih, sat4 plus mutations in gyrA, 23SrRNA and L22 were 
identified. Resistance genotypes were strongly linked with cgMLST200 type for certain groups including 
12/12 cgMLST200-510 with the A103V substitution in L22 and 10/11 cgMLST200-608 with the T86I GyrA 
substitution associated with macrolide and quinolone resistance, respectively. In summary, the 
cgMLST200 threshold scheme combined with resistance genotype information could provide an excellent 
subtyping scheme for source attribution of human C. jejuni infections. 
Keywords 
cgMLST, Campylobacter jejuni, source attribution, foodborne pathogens, PorA 
Disciplines 
Veterinary Pathology and Pathobiology 
Comments 
This article is published as Hsu, Chih-Hao, Lucas Harrison, Sampa Mukherjee, Errol Strain, Patrick 
McDermott, Qijing Zhang, and Shaohua Zhao. "Core Genome Multilocus Sequence Typing for Food Animal 
Source Attribution of Human Campylobacter jejuni Infections." Pathogens 9, no. 7 (2020): 532. DOI: 
10.3390/pathogens9070532. 
Authors 
Chih-Hao Hsu, Lucas Harrison, Sampa Mukherjee, Errol Strain, Patrick McDermott, Qijing Zhang, and 
Shaohua Zhao 
This article is available at Iowa State University Digital Repository: https://lib.dr.iastate.edu/vmpm_pubs/213 
pathogens
Article
Core Genome Multilocus Sequence Typing for Food
Animal Source Attribution of Human Campylobacter
jejuni Infections
Chih-Hao Hsu 1, Lucas Harrison 1,*, Sampa Mukherjee 1, Errol Strain 1, Patrick McDermott 1,
Qijing Zhang 2 and Shaohua Zhao 1
1 Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, MD 20708, USA;
Chih-Hao.Hsu@fda.hhs.gov (C.-H.H.); Sampa.Mukherjee@fda.hhs.gov (S.M.);
Errol.Strain@fda.hhs.gov (E.S.); Patrick.McDermott@fda.hhs.gov (P.M.); Shaohua.Zhao@fda.hhs.gov (S.Z.)
2 College of Veterinary Medicine, Iowa State University, Ames, IA 50010, USA; zhang123@iastate.edu
* Correspondence: Lucas.Harrison@fda.hhs.gov; Tel.: +1-(240)-402-3844; Fax: +1-(301)-210-4685
Received: 19 May 2020; Accepted: 29 June 2020; Published: 2 July 2020


Abstract: Campylobacter jejuni is a major foodborne pathogen and common cause of bacterial enteritis
worldwide. A total of 622 C. jejuni isolates recovered from food animals and retail meats in the
United States through the National Antimicrobial Resistance Monitoring System between 2013 and
2017 were sequenced using an Illumina MiSeq. Sequences were combined with WGS data of 222
human isolates downloaded from NCBI and analyzed by core genome multilocus sequence typing
(cgMLST) and traditional MLST. cgMLST allelic difference (AD) thresholds of 0, 5, 10, 25, 50, 100 and
200 identified 828, 734, 652, 543, 422, 298 and 197 cgMLST types among the 844 isolates, respectively,
and traditional MLST identified 174 ST. The cgMLST scheme allowing an AD of 200 (cgMLST200)
revealed strong correlation with MLST. cgMLST200 showed 40.5% retail chicken isolates, 56.5% swine,
77.4% dairy cattle and 78.9% beef cattle isolates shared cgMLST sequence type with human isolates.
All ST-8 had the same cgMLST200 type (cgMLST200-12) and 74.3% of ST-8 and 75% cgMLST200-12
were confirmed as sheep abortion virulence clones by PorA analysis. Twenty-nine acquired resistance
genes, including 21 alleles of blaOXA, tetO, aph(3′)-IIIa, ant(6)-Ia, aadE, aad9, aph(2′)-Ig, aph(2′)-Ih, sat4
plus mutations in gyrA, 23SrRNA and L22 were identified. Resistance genotypes were strongly linked
with cgMLST200 type for certain groups including 12/12 cgMLST200-510 with the A103V substitution
in L22 and 10/11 cgMLST200-608 with the T86I GyrA substitution associated with macrolide and
quinolone resistance, respectively. In summary, the cgMLST200 threshold scheme combined with
resistance genotype information could provide an excellent subtyping scheme for source attribution
of human C. jejuni infections.
Keywords: cgMLST; Campylobacter jejuni; source attribution; foodborne pathogens; PorA
1. Introduction
Campylobacter sp. are one of the leading causes of foodborne illness in the United States, causing
an estimated 1.5 million infections each year [1,2]. Worldwide, campylobacteriosis is the most common
cause of bacterial enteritis in humans with C. jejuni being the major contributor [3]. In otherwise healthy
individuals, C. jejuni infections commonly result in a self-limiting diarrheal disease that is believed
to commonly go unreported [4]. In immunocompromised patients, however, untreated C. jejuni
infections can progress to sepsis and in rare cases meningitis [5,6]. Further, C. jejuni is associated
with several sequelae including reactive arthritis, Guillain-Barre syndrome, Miller-Fisher syndrome
and prolonged exposure in infants is associated with growth deficits [7–9]. Although considered a
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foodborne pathogen in humans, C. jejuni can be acquired from a wide range of sources including
retail meats, raw milk, companion animals, fecal contamination, wild birds and other environmental
reservoirs [10,11]. C. jejuni is also increasingly viewed as a reservoir for antibiotic resistance genes in
both the environment and the food supply chain [2,12]. As a naturally competent organism, C. jejuni
is capable of incorporating exogenous DNA during logarithmic growth [13]. This ability to readily
acquire resistance genes from the environment enables Campylobacter strains to adapt to a range of
antibiotic selective pressures found across multiple types of food animal facilities. Campylobacter
species are also able to colonize food animals asymptomatically as a component of the gut microbiota
and persist in the production environment with no apparent cost to the host [14,15].
Studies evaluating the prevalence of Campylobacter species in retail meats have shown higher rates
in raw chicken (44%) compared to beef (0.5%) and pork (0.4%) sources [16]. While exposure to retail
chicken meat is a major risk factor for campylobacteriosis, many isolates from chicken carcasses at food
processing sites and retail chicken products do not show genetic relatedness to human pathogenic
strains [17–21]. Strains recovered from beef cattle, dairy cattle, chickens, turkeys, swine, sheep and
goats have all been linked to disease in humans [20,22]. This plurality of reservoirs demonstrates the
need to evaluate the pathogenic contribution of each source to inform better practices and reduce the
burden of campylobacteriosis on human health. The United States Department of Agriculture Food
Safety and Inspection Service (USDA-FSIS) NARMS screening for foodborne pathogens in the ceca of
several major food animals revealed prevalence of Campylobacter species in beef cattle (42%), dairy cattle
(43%) and swine (32%) at much higher rates than found in retail meats, suggesting that infection
from non-poultry animal sources may be underestimated [23]. The NARMS studies showed that high
prevalence populations of C. jejuni were present in more food animal sources than previously observed.
This broad range of food animal hosts combined with the potential for asymptomatic carriage and
environmental contamination all confound efforts to identify the source of Campylobacter infections.
Many C. jejuni strains exhibit a narrow range of host specificity and this trait can be used to
inform source attribution of strains that cause human infections [24,25]. However, strains with close
genetic similarity can infect different hosts and established typing methods such as pulsed field
gel electrophoresis (PFGE) or seven-gene multilocus sequence typing (MLST) lack the resolution to
distinguish between them [10,18,26–29]. One proposed solution to this limitation is core genome
fingerprinting, a method that expands on the seven loci of C. jejuni MLST to include 40 genomic targets
conserved across C. jejuni genomes [29]. While this aids in strain differentiation, it also results in a
labor-intensive set of five multiplexed PCR reactions. Analyses of the variable regions surrounding the
fla gene or CRISPR loci have also been introduced, but these are often used in conjunction with MLST
and incur a cost in labor [30].
In the last several years, whole genome sequencing (WGS) technology has been implemented in
many public health surveillance programs as a fast and affordable alternative to PFGE and MLST [31,32].
Using WGS data for analysis can overcome the limitations of PFGE and MLST by evaluating the
entire genome containing all housekeeping, virulence and resistance genes. Specifically, cgMLST
typing schemes using a core genome of 1343 loci found in >95% of C. jejuni strains have demonstrated
an increased discriminatory power over traditional MLST [33]. In a comparison of strains from
multiple campylobacteriosis outbreaks, this cgMLST application was able to group strains from the
same outbreak event into distinct clusters. We propose to explore the cgMLST approach further by
determining whether the ability of cgMLST to establish genomic relatedness could be used to inform
the source attribution of human pathogenic strains of C. jejuni. In the U.S., the contributions of PulseNet
and the National Antimicrobial Resistance Monitoring System (NARMS) surveillance programs to the
WGS repository maintained by NCBI provide an excellent source of foodborne pathogen sequence data
against which to validate our cgMLST typing scheme. The objective of this study is to evaluate the
utility of a cgMLST typing scheme for the source attribution of human pathogenic strains of C. jejuni.
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2. Results
2.1. MLST and cgMLST Diversity Indices
The discriminatory power of cgMLST typing was determined by the number of AD between
C. jejuni strains (Table S1). We compared and evaluated traditional seven-gene MLST and cgMLST
schema allowing for a range of 0 to 200 AD using Simpson’s index of diversity (Table 1). With regards
to this dataset, a diversity index (D.I.) score of 1.000 indicated each sequence type contained no more
than two strains while a D.I. lower than 1.000 represented a greater number of strains belonging to
fewer conserved, groups. All cgMLST allelic difference thresholds evaluated resulted in a greater
discriminatory power than traditional MLST. These results showed that the cgMLST scheme allowing
an allelic difference of 200 (cgMLST200) had a discriminatory power most like traditional MLST with
Simpson’s D.I. values of 0.964 vs. 0.963. The cgMLST200 schema classified the strains into 197 groups
while traditional MLST generated 174 groups. Further, decreasing the allowable allelic differences
generated a more stringent typing scheme resulting in an increasing number of highly related groups.
It has been proposed that using AD less than 10 can be used for foodborne outbreak investigation [34].
Table 1. Comparison of MLST and cgMLST Typing Methods.
Typing




D.I. Beef Chicken Dairy Human Swine
MLST 174 0.963 33 54 34 64 16
cgMLST200 197 0.964 38 102 40 87 18
cgMLST100 298 0.983 73 131 68 103 22
cgMLST50 422 0.991 115 150 107 122 22
cgMLST25 543 0.997 149 168 141 145 23
cgMLST10 652 0.999 175 187 162 156 23
cgMLST5 734 0.999 196 196 173 175 23
cgMLST0 828 1 211 205 180 216 23
* Typing groups may be found in multiple hosts.
2.2. Typing Schema and Source Attribution
To demonstrate the utility of the different typing methods for identifying the source of infection,
typing groups from cgMLST and traditional MLST were evaluated by host origin. Specifically, cgMLST
groups were classified by the property of containing strains isolated from humans. The ratio of isolates
recovered from humans to isolates from each of the other sources was determined using cgMLST
and traditional MLST (Figure 1). Traditional MLST and cgMLST200 typing methods showed similar
representation of human pathogenic strains across all four food animal sources. The cgMLST200 scheme
showed that 40.5% of isolates from retail chicken, 56.5% from swine, 77.4% from dairy cattle and 78.9%
from beef cattle shared the same cgMLST type with isolates recovered from humans. In comparison,
traditional MLST showed 53.6% of isolates from retail chicken, 56.5% from swine, 78.4% from dairy
cattle and 81.7% from beef cattle were classified in human pathogenic typing groups. The prevalence
of human pathogenic strains in these food animal sources is similar to previous analyses using a PFGE
typing method [18]. Further, the similar contribution of human pathogenic strains between beef cattle
and dairy cattle reflect a conserved composition of C. jejuni strains, as indicated by population analysis
(Figure S1).
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into human pathogenic groups (Figure S3). Specific to groups containing isolates from humans, the 
cgMLST200 scheme identified 87 groups encompassing 404 strains, 222 of which were isolated from a 
human source (55%) while the more stringent cgMLST5 scheme identified 175 groups with 243 
strains, 222 from a human source (91.4%). This trend of increased stringency favoring a more 
homologous source composition was conserved for all C. jejuni sources evaluated (Figure 2). 
Figure 1. Proportion of C. jejuni from each source sharing a typing group with strains known to cause
disease in humans. Column height indicates the percentage of strains from each source (beef, dairy,
chicken or swine) that were classified in a group that contained human pathogenic strains of C. jejuni.
The dashed line indicates the percentage of strains found in typing groups unique to humans.
The simil rities between traditional MLST a d cgMLST were consistent with t e diversity indices
calculated earlier (Table 1). The stringency of grouping criteria (i.e., the threshold of differences
between groups) reflected the number of isolat s from n n-human sources categ rized into human
pathogenic groups (Figure S3). Specific to groups containing isolates from humans, the cgMLST200
scheme identified 87 groups encompassing 404 strains, 222 of which were isolated from a human source
(55%) while the more stringent cgMLST5 scheme identified 175 groups with 243 strains, 222 from
a human source (91.4%). This trend of increased stringency favoring a more homologous source
composition was conserved for all C. jejuni sources evaluated (Figure 2).
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were found in ST 577, 61, 1244, 459 and 922 (Table S2). The cgMLST200-12 group contained 76 strains, 
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Figure 2. (A) Venn diagrams showing the number of cgMLST patterns associated with each source for
traditional MLST (upper), cgMLST200 (middle) and cgMLST5 (lower). Patterns are numbered by total
(left) followed by those shared with human pathogenic strains (right). (B) Distribution of individual
strains belonging to the human pathogenic patterns in A. Isolates recovered from humans found in
typing groups unique to humans are listed below for each typing scheme. Group totals correspond
with A. and source identification is as follows: Beef (B), Dairy (D), Swine (S) and Chicken (C).
2.3. Validation of Typing Schema
One test of the utility of a typing scheme is its ability to categorize strains with phenotypically
distinct traits into discre e groups. Traditional MLST has been shown to successfully categorize the
sheep abortion (SA) st ains of C. jejuni nto ST-8 [35]. To validate the yping utility of the cgMLST
ch me, we evaluated the distributio of strains with the SA-associated PorA sequence across both
cgMLST200 and sev n-g ne MLST sequence types. All 74 strains identified as ST-8, as sequence
type linked to the SA-associated PorA s quence, were classifie into a single cgMLST200 group,
cgMLST200-12. Within th entire population, 87/844 (10.3%) of he strains encoded for the SA-associated
PorA sequenc . The MLST-8 gr up contained 74 strains, 55 (74.3%) of which encoded the SA- ssociated
PorA sequenc (Table 2). The remain g 13 strains encoding for the SA-associated PorA sequence were
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found in ST 577, 61, 1244, 459 and 922 (Table S2). The cgMLST200-12 group contained 76 strains, 57 of
which (75%) had the SA-associated PorA, showing the cgMLST200-12 to be slightly better for classifying
SA clones in this set of 844 Campylobacter genomes. Overlay of PorA annotation data onto a minimum
spanning tree of cgMLST type revealed two clusters harboring the majority of strains encoding for the
SA-associated PorA sequence: cgMLST200-12 and cgMLST200-50 (Figure S2). When the allelic difference
threshold was decreased from 200 to 50, stronger associations between typing groups were observed.
For example, 51/55 (92.7%) of cgMLST50-136, 9/10 (90%) of cgMLST50-15 and 6/7 (85.7%) cgMLST50-51
strains encoded for the SA-associated PorA sequence. The cgMLST50-136 group contained one of
the isolates with the SA-associated PorA sequence not accounted for in the traditional ST-8 group.
Together, these results indicate that cgMLST200-12 and ST-8 predominate but not exclusively harbor
the SA-associated PorA variant.
Table 2. Alignment of PorA SA Determinant Region between Sequence Types.
Sequence a,b,c
cgMLST200-12
vs. MLST-8 d Description
170- * * * * * * * * * * * −209 Conserved residues
NCTC11168 FMAAEQGADLLEHSNISTTS NQAPFKVDSVGNLY Reference sequence
N48272F FMAEEQGADLLGKST ISTTQKAAPFQADSLGNLY 55:53 SA clonal sequence
N43804F FMAEEQGADLLGKST ISIT QKAAPFQADSLGNLY 1:1 Substitution not in SA loci
N45191FR FMAEEQGT DLLGKST ISTTQKAAPFQADSLGNLY 1:1 Substitution not in SA loci
N46355F FMAEEQGADLLGKSTISTT QKAAPFQTNSLGNLY 1:1 Substitution in SA loci
N49694F FMEKEQ I S DLVG SNSSTFNVDSI GNLY 16:16 Deletion and substitutions in SA loci
N44409F FMAAEQSS DLVG ANGSAFKVDSI ENLY 1:1 Deletion and substitutions in SA loci
N45200F FMAKEQGSDLVG ANGSAFNVDSIGNLY 1:1 Deletion and substitutions in SA loci
a * indicates conserved residue at sequence position, b Bold formatting indicates amino acid substitution associated
with the SA phenotype, c Underline formatting indicates amino acid substitution not associated with the SA
phenotype, d cgMLST200-12 (left) and MLST-8 (right) isolates identified with the corresponding PorA aa sequence.
2.4. Antimicrobial Resistance Genotypes and cgMLST
A total of 29 unique antimicrobial resistance genes were identified in the 844 Campylobacter
genomes, including 21 alleles of blaOXA, tetO, aph(3′)-IIIa, aadE, aad9, aph(2′)-Ih, aph(2′)-h and sat4.
Antimicrobial resistance mutations and substitutions were observed among 271 strains, including GyrA
at aa 68 (n = 168), 23SrRNA at bp 2074 (n = 3), 23SrRNA at bp 2075 (n = 8), 50SL22 at aa 103 (n = 112),
RpsL at aa 43 (n = 2) and RpsL at aa 88 (n = 2). Certain cgMLST200 groups had conserved antimicrobial
resistance genotypes. In total, 12/12 cgMLST200-4 and 6/6 cgMLST200-584 strains carried both blaOXA-193
and tetO, 12/12 cgMLST200-510 had the A103V substitution in L22, and 10/11 cgMLST200-608 the T86I
substitution in GyrA. The tetO gene was also present in 74/76 cgMLST200-12 isolates. Within the
population of 844 Campylobacter isolates, 636 encoded for a blaOXA gene. The most prevalent allele
was blaOXA-193, present in 398 strains in all five host types evaluated. The remaining blaOXA alleles
demonstrated specificity towards certain human sequence types. Of the Campylobacter strains isolated
from humans, 10/10 cgMLST200-86 encoded blaOXA-61, 8/8 cgMLST200-510 encoded blaOXA-603, 5/5
cgMLST200-76 encoded blaOXA-449 and 4/4 cgMLST200-435 encoded blaOXA-447 (Table S1).
The above antibiotic resistance patterns were then evaluated to determine if antibiotic resistance
determinants could be used in conjunction with sequence type as an indicator of isolate source.
The cgMLST200-4 group isolates were obtained from all host types evaluated, including beef, chicken,
dairy, swine and human while the cgMLST200-584 group were obtained from either chicken or human.
cgMLST200-510 isolates were obtained from chicken, swine and human sources and the cgMLST200-608
type was only found in chicken. Evaluating the blaOXA family of genes, only blaOXA-61 was able to
help inform host source as no dairy cattle from that group encoded blaOXA-61. These data indicate that
while antibiotic resistance determinants were restricted to sequence types, the distribution of alleles
within a sequence type was not limited to a specific host.
3. Discussion
The cgMLST scheme described here provides a convenient strategy for strain typing by evaluating
the 1343 loci present in the core genome of C. jejuni. This increased resolution over traditional
seven-gene MLST allows cgMLST typing schemes to more accurately inform the source of human
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pathogenic C. jejuni strains. One factor that complicates the use of traditional MLST for source
attribution is the ability of C. jejuni to infect multiple host types [36]. Using the cgMLST approach, we
have demonstrated that allowing fewer allelic differences between isolates segregates strains from
different sources into discrete groups (Figure 2). Further, source composition analysis of the typing
groups reveals which sources harbor the greatest number of human pathogenic strains. In addition to
reducing the number of potential sources, the allelic threshold informs the degree of genetic relatedness
between human pathogenic strains and human non-pathogenic strains from known sources (Table 3).
Table 3. Source Attribution of C. jejuni Isolates across Multiple Typing Schema.
Strain
ID MLST cgMLST200 cgMLST5 cgMLST0
Group ID Source * Group ID Source Group ID Source Group ID Source
N46804F 982 B,D,H 28 B,C,D,H,S 57 D,H 250 D
SRR5217159 982 B,D,H 28 B,C,D,H,S 57 D,H 754 H
N45809F 982 B,D,H 28 B,C,D,H,S 209 D,H 209 D
SRR5878335 982 B,D,H 28 B,C,D,H,S 209 D,H 826 H
N48272F 8 B,C,D,H,S 12 B,C,D,H,S 223 D,H 291 D
SRR2970498 8 B,C,D,H,S 12 B,C,D,H,S 223 D,H 528 H
N50152F 806 B,D,H,S 18 B,D,H,S 362 B,H 362 B
SRR5604241 806 B,D,H,S 18 B,D,H,S 362 B,H 806 H
SRR5152202 50 C,D,H 100 C,D,H 400 C,H 719 C
SRR1794080 50 C,D,H 100 C,D,H 400 C,H 400 H
SRR2075414 45 B,C,D,H,S 407 C,H 407 C,H 407 C
SRR3029056 45 B,C,D,H,S 407 C,H 407 C,H 407 H
SRR2094236 353 C,D,H 412 C,H 412 C,H 412 C
SRR2182579 353 C,D,H 412 C,H 412 C,H 444 H
SRR3092138 52 C,H,S 510 C,H,S 512 S,H 822 S
SRR5754156 52 C,H,S 510 C,H,S 512 S,H 551 H
SRR5152177 2083 C,H 584 C,H 593 C,H 714 C
SRR5932391 2083 C,H 584 C,H 593 C,H 833 H
* Beef (B), Dairy (D), Human (H), Chicken (C) and Swine (S).
Earlier approaches to increase the resolution of sequence typing methods have incorporated
genomic determinants of antibiotic resistance [24,25]. In this study, 102 unique combinations of
antibiotic resistance determinants were present in our population of C. jejuni isolates, with tet(O) and
blaoxa alleles present in isolates obtained from each source evaluated (Table S3). Our data revealed
an interesting trend in antibiotic resistance between the food animal groups. Specifically, none of
the determinants of macrolide resistance in the AMRFinder database were found in either beef or
dairy cattle, food animal sources where macrolides are commonly administered by injection Although
macrolides (e.g., tylosin) can apply selective pressure on C. jejuni during food animal production,
the associated resistance determinants were absent in isolates recovered from the beef and dairy
cattle populations in our study [37,38]. Interestingly, while two-thirds of the strains with macrolide
resistance determinants were isolated from chicken sources, these same substitutions have been shown
to incur a fitness cost and growth rate decrease in chickens in the absence of antibiotic selection
pressure [39]. Strains lacking these substitutions have been shown to outcompete macrolide-resistant
mutant strains [40,41]. In light of this, the absence of macrolide resistance determinants in isolates
from our cattle populations compared to a 52.7% prevalence in our population of chicken isolates
suggests that the distribution of macrolide resistance between these animal sources is not random.
One limitation of this study is that we do not have direct epidemiological evidence linking a
pathogen from a specific source and sequence type to human disease. cgMLST shows strong genetic
relatedness between human and non-human sourced isolates of C. jejuni; however, we currently lack
the epidemiological metadata necessary to determine causality. We may conclude that there are strains
of C. jejuni isolated from humans very closely related to strains isolated from food animal sources,
differing only by the sequence of five alleles. A further limitation of the study is the underrepresentation
of C. jejuni isolates from swine. While the sample size is too small to draw conclusions from our swine
strains, we have demonstrated that a subset of isolates capable of infecting swine share a close genetic
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relatedness (i.e., AD < 5) with isolates that also infect humans, beef cattle, dairy cattle and chickens.
The genomic similarity of these strains from different hosts suggests that these sequence types identify
strains with a less restricted host range.
Source attribution of C. jejuni infections allows food industry professionals to tailor their practices
to prevent the spread of foodborne pathogens. It also enables healthcare professionals to more
efficiently use resources to contain the source of the disease. Similar to previous work, we used cgMLST
to identify groups of genetically related strains of human pathogenic C. jejuni [33]. Expanding on this,
we were also able to evaluate the cooccurrence of cgMLST groups, host source and antibiotic resistance
determinants to identify which food sources harbor strains most closely related to pathogens that cause
disease in humans. Our data demonstrate that evaluating Campylobacter strains across the 1343 loci
of the cgMLST typing scheme provides a higher resolution method to determine genomic relatedness
compared to traditional seven-gene MLST. Additionally, cgMLST typing has the potential to inform
clinical decisions as the associations between cgMLST type and antibiotic resistance are established.
Finally, as WGS data become more widely available, cgMLST typing serves as a cost-effective method
for comparing multiple stains of C. jejuni. In conclusion, the cgMLST200 threshold combined with
resistance genotype could provide an excellent subtyping scheme for source attribution of human
C. jejuni infections.
4. Materials and Methods
4.1. Bacterial Strains and Sequencing
A total of 622 C. jejuni isolates recovered from food animals and retail meats were collected
through NARMS starting in 2013 [42]. C. jejuni strains were obtained from the following sources: beef
cattle cecal isolates (n = 213), dairy cattle cecal isolates (n = 181), chicken cecal isolates (n = 11), chicken
retail meat isolates (n = 194) and swine cecal isolates (n = 23). Genomic DNA was extracted using the
Qiagen DNeasy Blood and Tissue kit (Qiagen, Gaithersburg, MD) and genomes were sequenced on
an Illumina MiSeq using v3 chemistry (Illumina, San Diego, CA). C. jejuni genomes were assembled
using the de Brujin graph assembler from the CLC Genomics Workbench version 8.0 (CLC bio Aarhus,
Denmark). These sequence data with a mean coverage of 51.37 were added to a collection of 222
sequences of human pathogenic C. jejuni that were submitted to the National Center for Biotechnology
Information (NCBI) by the Centers for Disease Control and Prevention (CDC) to generate the pool of
844 genomes used in this project.
4.2. Traditional Multilocus Sequence Typing
The analysis of traditional seven-gene MLST was performed using whole-genome sequencing
(WGS) data. Campylobacter multilocus sequence typing (MLST) allelic profiles and sequences were
downloaded from the PubMLST database [43]. A total of 9098 profiles for seven different loci were used
for the MLST analysis. The SRST2 pipeline was used to determine the MLST type for our Campylobacter
isolates [44].
4.3. Core Genome MLST
The cgMLST scheme of 1343 loci, defined from 2742 Campylobacter isolates from Oxfordshire, UK,
between 2011 and 2014, was downloaded from the PubMLST online database and queried against our
collection of 844 C. jejuni using a BLAST search [33,43]. As the core genome represents genes present in
>95% C. jejuni strains, up to 100 missing alleles were allowed for each genome [33]. The core-genome
sequence type (cgST) for each isolate was determined based on the cgMLST scheme and a new cgST
was assigned to a genome if the combination of alleles for the genome was not found in the cgMLST
scheme. The cgST and allele composition for all genomes were assigned to the allelic profiles where
missing alleles were represented with an “N”. Graphical representations of the population as minimum
spanning trees from cgMLST data were generated using GrapeTree [45].
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4.4. Hierarchical Clustering of cgMLST Data
Distance between genomes was calculated based on the pairwise distance between allelic profiles
and was measured as allelic difference (AD). All genomes were clustered on seven different levels of
AD: 0, 5, 10, 25, 50, 100 and 200 using the single-linage clustering method. With this method, a genome
was linked to a group if the genome had less than or equal to the threshold number of AD with at least
one other genome of that group. Genomes clustered together at each AD threshold were assigned the
same group ID.
4.5. Analysis of Population Composition
Underlying population composition was determined using STRUCTURE software v2.3.4 to
analyze allele profiles across the 1343 loci of the C. jejuni core genome for the 844 strains present in this
study. Software parameters were informed by prior source attribution studies and are described as
follows [46]. The program was run using 50,000 burn-in iterations followed by 50,000 iterations applying
a no-admixture model and assuming allele frequencies were independent. Source population was used
to inform the analysis, however strains originating from humans were not used in model generation.
4.6. Identification of Antimicrobial Resistance Genotypes
Antimicrobial resistance genes were identified using the AMRFinder tool [47] that uses a curated
AMR gene reference database of 4579 antimicrobial resistance proteins, more than 560 hidden Markov
models (HMMs) and a curated protein family hierarchy. AMRFinder was also used to identify antibiotic
resistance determinants in Campylobacter, including mutations and substitutions in the gyrA gene, 23S
ribosomal RNA, 50S ribosomal protein L22 and 30S ribosomal protein S12 RpsL.
4.7. PorA Analysis
The sequence variation of the major outer membrane protein (PorA) is implicated in pathogenesis
of C. jejuni [48]. The PorA sequence of the reference strain NCTC11168 was downloaded from NCBI
GenBank as a wild-type comparator. This sequence was compared to our collection of 844 C. jejuni
using an in-house perl script to determine the population-wide distribution of allelic variations of
the loop 4 region in PorA, a region associated with a C. jejuni phenotype that can result in abortions
in sheep. Isolates encoding a PorA sequence with less than 70% identity to the comparator strain
NCTC11168 were excluded, leaving 739 Campylobacter isolates used in the PorA analysis. The loop 4
region of the sheep abortion (SA) associated PorA sequence was queried against the remaining C. jejuni
sequences using blastx, and the results were aligned with ClustalW. The sequences were then visualized
using MAFFT through EMBL to identify isolates with the SA-associated PorA sequence [49]. Sequence
typing results from MLST and cgMLST were compared against the presence of the SA-associated PorA
sequence to evaluate the ability of each typing scheme to identify SA strains of C. jejuni.
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